Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Invasive Breast Cancer × cemiplimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Carcinoma, Squamous Cell 3 Recurrence 2 Lung Neoplasms 2 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Motor Activity 1 Lymphoma, B-Cell 1 Laryngeal Neoplasms 1 Invasive Breast Cancer 1 Hypopharyngeal Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioblastoma 1 Cutaneous Squamous Cell Carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Non-small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1 Advanced Malignancies 1

Interventions

Surgical Procedures, Operative 2 Paclitaxel 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Trastuzumab 1 Radiotherapy 1 Indocyanine Green 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡